Lymphatic vascular invasion is an independent correlated factor for lymph node metastasis and the prognosis of resectable T2 gastric cancer patients

[1]  A. Meloni-Ehrig,et al.  Gastric cancer: Classification, histology and application of molecular pathology. , 2012, Journal of gastrointestinal oncology.

[2]  M. Choi,et al.  Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer , 2012, The British journal of surgery.

[3]  J. Slater,et al.  Proton therapy for gastrointestinal cancers , 2012 .

[4]  K. Tamura.  Medical oncology in Asia. , 2012, Chinese clinical oncology.

[5]  G. Alpini,et al.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings. , 2012, Translational gastrointestinal cancer.

[6]  Yixing Jiang.  Multidisciplinary approach for the treatment of gastric cancer , 2012 .

[7]  S. Groshen,et al.  Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. , 2011, Journal of gastrointestinal oncology.

[8]  C. V. D. Velde,et al.  Gastric cancer – Authors' reply , 2009, The Lancet.

[9]  C. V. D. Velde,et al.  Gastric cancer , 2009, The Lancet.

[10]  D. Nitti,et al.  Prognostic value of subclassification of T2 tumours in patients with gastric cancer , 2009, The British journal of surgery.

[11]  F. Vizoso,et al.  Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance , 2008, Journal of Cancer Research and Clinical Oncology.

[12]  Yasuo Ohashi,et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. , 2007, The New England journal of medicine.

[13]  Jen-Hao Chen,et al.  Nodal dissection for patients with gastric cancer: a randomised controlled trial. , 2006, The Lancet. Oncology.

[14]  John R. Mackey,et al.  Gastric Adenocarcinoma: Review and Considerations for Future Directions , 2005, Annals of surgery.

[15]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[16]  Jun Liang,et al.  Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study , 2012 .

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.